trial · primary record
CT-868
Overweight
| Phase | Phase 2 |
|---|---|
| Status | COMPLETED |
| Sponsor | Unknown |
| Enrolment | 111 |
| Primary completion | 2025-07-07 |
| Primary endpoint | Change From Baseline in Glycated Hemoglobin (HbA1c) (%) at Week 16 |
| Registry ID | NCT06062069 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T13:42:59.599Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06062069
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.